These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9377090)
1. Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments. Cros S; Petitou M; Sizun P; Pérez S; Imberty A Bioorg Med Chem; 1997 Jul; 5(7):1301-9. PubMed ID: 9377090 [TBL] [Abstract][Full Text] [Related]
2. Conformations of the iduronate ring in short heparin fragments described by time-averaged distance restrained molecular dynamics. Muñoz-García JC; Corzana F; de Paz JL; Angulo J; Nieto PM Glycobiology; 2013 Nov; 23(11):1220-9. PubMed ID: 23903025 [TBL] [Abstract][Full Text] [Related]
3. Heavy metal binding to heparin disaccharides. I. Iduronic acid is the main binding site. Whitfield DM; Choay J; Sarkar B Biopolymers; 1992 Jun; 32(6):585-96. PubMed ID: 1643264 [TBL] [Abstract][Full Text] [Related]
4. An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides. Chuang WL; Christ MD; Peng J; Rabenstein DL Biochemistry; 2000 Apr; 39(13):3542-55. PubMed ID: 10736153 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin III. Petitou M; Duchaussoy P; Lederman I; Choay J; Sinaÿ P; Jacquinet JC; Torri G Carbohydr Res; 1986 Mar; 147(2):221-36. PubMed ID: 3708627 [TBL] [Abstract][Full Text] [Related]
6. Effect of the substituents of the neighboring ring in the conformational equilibrium of iduronate in heparin-like trisaccharides. Muñoz-García JC; López-Prados J; Angulo J; Díaz-Contreras I; Reichardt N; de Paz JL; Martín-Lomas M; Nieto PM Chemistry; 2012 Dec; 18(51):16319-31. PubMed ID: 23143902 [TBL] [Abstract][Full Text] [Related]
8. B3LYP/6-311++G** study of structure and spin-spin coupling constant in methyl 2-O-sulfo-alpha-L-iduronate. Hricovíni M Carbohydr Res; 2006 Nov; 341(15):2575-80. PubMed ID: 16930570 [TBL] [Abstract][Full Text] [Related]
9. Conformation and dynamics of heparin and heparan sulfate. Mulloy B; Forster MJ Glycobiology; 2000 Nov; 10(11):1147-56. PubMed ID: 11087707 [TBL] [Abstract][Full Text] [Related]
10. Depiction of the forces participating in the 2-O-sulfo-alpha-L-iduronic acid conformational preference in heparin sequences in aqueous solutions. Pol-Fachin L; Verli H Carbohydr Res; 2008 Jul; 343(9):1435-45. PubMed ID: 18452898 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin. Sisu E; Tripathy S; Mallet JM; Driguez PA; Hérault JP; Sizun P; Herbert JM; Petitou M; Sinay P Biochimie; 2003; 85(1-2):91-9. PubMed ID: 12765779 [TBL] [Abstract][Full Text] [Related]
12. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III. Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563 [TBL] [Abstract][Full Text] [Related]
13. Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid. Elli S; Stancanelli E; Wang Z; Petitou M; Liu J; Guerrini M Chemistry; 2020 Sep; 26(51):11814-11818. PubMed ID: 32515841 [TBL] [Abstract][Full Text] [Related]
14. Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. Torri G; Casu B; Gatti G; Petitou M; Choay J; Jacquinet JC; Sinaÿ P Biochem Biophys Res Commun; 1985 Apr; 128(1):134-40. PubMed ID: 3985961 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin. Das SK; Mallet JM; Esnault J; Driguez PA; Duchaussoy P; Sizun P; Herault JP; Herbert JM; Petitou M; Sinaÿ P Chemistry; 2001 Nov; 7(22):4821-34. PubMed ID: 11763451 [TBL] [Abstract][Full Text] [Related]
16. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor. Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554 [TBL] [Abstract][Full Text] [Related]
17. A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation. Petitou M; Barzu T; Herault JP; Herbert JM Glycobiology; 1997 Apr; 7(3):323-7. PubMed ID: 9147040 [TBL] [Abstract][Full Text] [Related]
18. Conformation of the pentasaccharide corresponding to the binding site of heparin for antithrombin III. Ragazzi M; Ferro DR; Perly B; Sinaÿ P; Petitou M; Choay J Carbohydr Res; 1990 Jan; 195(2):169-85. PubMed ID: 2331700 [TBL] [Abstract][Full Text] [Related]
19. Solution structure of a trisaccharide-antibody complex: comparison of NMR measurements with a crystal structure. Bundle DR; Baumann H; Brisson JR; Gagné SM; Zdanov A; Cygler M Biochemistry; 1994 May; 33(17):5183-92. PubMed ID: 8172893 [TBL] [Abstract][Full Text] [Related]
20. The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. Mulloy B; Forster MJ; Jones C; Drake AF; Johnson EA; Davies DB Carbohydr Res; 1994 Mar; 255():1-26. PubMed ID: 8181000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]